These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 30124149)
21. Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases. Yue Q; Song Y; Liu Z; Zhang L; Yang L; Li J Molecules; 2022 Aug; 27(15):. PubMed ID: 35956875 [TBL] [Abstract][Full Text] [Related]
22. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses. Oczypok EA; Perkins TN; Oury TD Paediatr Respir Rev; 2017 Jun; 23():40-49. PubMed ID: 28416135 [TBL] [Abstract][Full Text] [Related]
23. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women. Pertynska-Marczewska M; Merhi Z Reprod Sci; 2015 Jul; 22(7):774-82. PubMed ID: 25228634 [TBL] [Abstract][Full Text] [Related]
24. Identification of pheophorbide a as an inhibitor of receptor for advanced glycation end products in Mallotus japonicus. Matsumoto T; Matsuno M; Ikui N; Mizushina Y; Omiya Y; Ishibashi R; Ueda T; Mizukami H J Nat Med; 2021 Jun; 75(3):675-681. PubMed ID: 33625682 [TBL] [Abstract][Full Text] [Related]
25. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease. Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680 [TBL] [Abstract][Full Text] [Related]
26. The RAGE signaling in osteoporosis. Zhou J; Liu S; Bi S; Kong W; Qian R; Xie X; Zeng M; Jiang X; Liao Z; Shuai M; Liu W; Cheng L; Wu M Biomed Pharmacother; 2023 Sep; 165():115044. PubMed ID: 37354815 [TBL] [Abstract][Full Text] [Related]
27. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway. Kim DY; Kang MK; Lee EJ; Kim YH; Oh H; Kang YH Mol Nutr Food Res; 2018 Oct; 62(19):e1800302. PubMed ID: 29987888 [TBL] [Abstract][Full Text] [Related]
28. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Stern D; Yan SD; Yan SF; Schmidt AM Adv Drug Deliv Rev; 2002 Dec; 54(12):1615-25. PubMed ID: 12453678 [TBL] [Abstract][Full Text] [Related]
29. The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease. Sharma A; Kaur S; Sarkar M; Sarin BC; Changotra H Clin Rev Allergy Immunol; 2021 Apr; 60(2):244-258. PubMed ID: 33170477 [TBL] [Abstract][Full Text] [Related]
30. The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications. Ramasamy R; Shekhtman A; Schmidt AM Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562970 [TBL] [Abstract][Full Text] [Related]
31. Perspectives on signaling for biological- and processed food-related advanced glycation end-products and its role in cancer progression. Eva TA; Barua N; Chowdhury MM; Yeasmin S; Rakib A; Islam MR; Emran TB; Simal-Gandara J Crit Rev Food Sci Nutr; 2022; 62(10):2655-2672. PubMed ID: 33307763 [TBL] [Abstract][Full Text] [Related]
32. Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention. Yamagishi SI Circ J; 2019 Aug; 83(9):1822-1828. PubMed ID: 31366777 [TBL] [Abstract][Full Text] [Related]
33. Assay for advanced glycation end products generating intracellular oxidative stress through binding to its receptor. Kobori T; Ganesh D; Kumano-Kuramochi M; Torigoe K; Machida S Anal Biochem; 2020 Dec; 611():114018. PubMed ID: 33186591 [TBL] [Abstract][Full Text] [Related]
34. Hypoxia driven glycation: Mechanisms and therapeutic opportunities. Khan MI; Rath S; Adhami VM; Mukhtar H Semin Cancer Biol; 2018 Apr; 49():75-82. PubMed ID: 28546110 [TBL] [Abstract][Full Text] [Related]
35. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Schmidt AM; Yan SD; Wautier JL; Stern D Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470 [TBL] [Abstract][Full Text] [Related]
36. The Potential of Receptor for Advanced Glycation End Products (RAGE) as a Therapeutic Target for Lung Associated Diseases. Khaket TP; Kang SC; Mukherjee TK Curr Drug Targets; 2019; 20(6):679-689. PubMed ID: 30457049 [TBL] [Abstract][Full Text] [Related]
37. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products. Miyoshi A; Koyama S; Sasagawa-Monden M; Kadoya M; Konishi K; Shoji T; Inaba M; Yamamoto Y; Koyama H FASEB J; 2019 Mar; 33(3):3575-3589. PubMed ID: 30452882 [TBL] [Abstract][Full Text] [Related]
38. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions. Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409 [TBL] [Abstract][Full Text] [Related]
39. Advanced glycation end products decrease collagen I levels in fibroblasts from the vaginal wall of patients with POP via the RAGE, MAPK and NF-κB pathways. Chen YS; Wang XJ; Feng W; Hua KQ Int J Mol Med; 2017 Oct; 40(4):987-998. PubMed ID: 28849117 [TBL] [Abstract][Full Text] [Related]
40. Astrocyte´s RAGE: More Than Just a Question of Mood. Gonzalez-Reyes RE; Rubiano MG Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):39-48. PubMed ID: 27149992 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]